Department of Urology Grand Rounds: Facundo Davaro, MD

The University of Florida Department of Urology invites you to attend Grand Rounds:

Monday, December 12, 2022
7:00 am – 8:00 am
Urology Conference Room M2-203C

“Plasmacytoid Urothelial Carcinoma: Past, Present & Future”

doctor davaro is wearing a black suit jacket and black tie with white collared shirt.

Facundo Davaro, MD
Urologic Oncology Fellow
H. Lee Moffitt Cancer Center & Research Institute


Upon completion of this activity, participants should be able to: 

  1. Summarize past research in variant histology bladder cancer
  2. Evaluate the genomic landscape of plasmacytoid urothelial carcinoma
  3. Analyze the current evidence for systemic & surgical therapy
  4. Explore future directions in plasmacytoid urothelial carcinoma research


Dr. Davaro has disclosed that he has no relevant financial relationships. Planning committee member Vincent Bird, MD has disclosed that he is a consultant for Boston Scientific. No one else in a position to control content has any financial relationships to disclose. Conflict of interest information for the CME Advisory Committee members can be found on the following website: All relevant financial relationships have been mitigated. 


The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.   


The University of Florida College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

For additional information, contact Stephanie Stenner at 352/273-8634 or e-mail 

Section # 2115

logo that reads uf college of medicine department of urology university of Florida. The letters are in dark blue and there is dark orange vertical line between the UF and the reset of the words.


Florida’s Leading Academic Urology Program

Rated as High Performing Urology Program

Rated as High Performing in Prostate Cancer Surgery